InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
3
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by Canaan XI L.P.. Director active across 2 companies, notably Day One Biopharmaceuticals, Inc.. In total, 7 disclosures have been logged. Breakdown: 0 buy · 3 sells. Total volume traded: €16m. History available since 13 September 2022. The latest transaction was disclosed on 21 September 2022 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Canaan XI L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
607,497 shares@ US$18.5471.7% of flowCommon StockSEC:0000899243-22-031692:0
111,585 shares@ US$21.5315.1% of flowCommon StockSEC:0000899243-22-031602:0
86,644 shares@ US$24.3913.2% of flowCommon StockSEC:0000899243-22-031191:0
536,000 sharesCommon StockSEC:0000899243-21-049399:0
536,000 sharesCommon StockSEC:0000899243-21-047572:0
3,936,595 sharesCommon StockSEC:0000899243-21-036606:0
7,328,497 sharesCommon StockSEC:0000899243-21-021571:0
7 of 7 declarations
About Canaan XI L.P.
Canaan XI L.P. is a director and insider at Day One Biopharmaceuticals, Inc. and Tyra Biosciences, Inc.
